Literature DB >> 25362713

Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis.

Ana-Maria Orbai1, Joshua Weitz2, Evan L Siegel2, Stefan Siebert2, Laura J Savage2, Sibel Z Aydin2, Jolanda J Luime2, Ori Elkayam2, Barbara Neerinckx2, Slavo Urbancek2, Kurt de Vlam2, Christopher T Ritchlin2.   

Abstract

Enthesitis is a characteristic feature of psoriatic arthritis (PsA) and is important in disease pathogenesis and classification. Use of clinical outcome measures for enthesitis is heterogeneous, and only 1 measure has been specifically developed and validated in PsA. Ultrasound and magnetic resonance imaging assessments of enthesitis may have advantages over clinical examination but are insufficiently studied. As part of an update of treatment recommendations by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), we performed a systematic literature review and identified randomized controlled trials with enthesitis outcomes in PsA. For each treatment agent we calculated treatment effect sizes (where applicable) and graded the level of evidence.

Entities:  

Keywords:  ENTHESITIS; ENTHESOPATHY; OUTCOME MEASURES; PSORIATIC ARTHRITIS; TREATMENT

Mesh:

Substances:

Year:  2014        PMID: 25362713     DOI: 10.3899/jrheum.140878

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  [Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

Authors:  F Behrens; D Thaçi; J Wollenhaupt; K Krüger
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

2.  Peripheral Enthesitis in Spondyloarthritis: Lessons from Targeted Treatments.

Authors:  Gurjit S Kaeley; Jaspreet K Kaler
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

Review 3.  Making the next steps in psoriatic arthritis management: current status and future directions.

Authors:  Diviya Sritheran; Ying Ying Leung
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

Review 4.  Entheseal involvement in systemic disorders.

Authors:  Gleb Slobodin; Doron Rimar; Nina Boulman; Lisa Kaly; Michael Rozenbaum; Itzhak Rosner; Majed Odeh
Journal:  Clin Rheumatol       Date:  2015-09-10       Impact factor: 2.980

Review 5.  [Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

Authors:  F Behrens; D Thaçi; J Wollenhaupt; K Krüger
Journal:  Z Rheumatol       Date:  2016-06       Impact factor: 1.372

Review 6.  Measuring Outcomes in Psoriatic Arthritis.

Authors:  Alexis Ogdie; Laura C Coates; Philip Mease
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

7.  Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions.

Authors:  Kemal Nas; Erkan Kiliç; Remzi Çevik; Hatice Bodur; Şebnem Ataman; Figen Ayhan; Özgür Akgül; Ayşen Akinci; Zuhal Altay; Erhan Çapkın; Abdullah Zübeyir Dağli; Tuncay Duruöz; Gülcan Gürer; Feride Göğüş; Yeşim Garip; Cahit Kaçar; Ayhan Kamanli; Ece Kaptanoğlu; Taciser Kaya; Hilal Kocabaş; Erhan Ali Özdemirel; Sumru Özel; İlhan Sezer; İsmihan Sunar; Gürkan Yilmaz
Journal:  Arch Rheumatol       Date:  2018-05-21       Impact factor: 1.472

8.  The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies.

Authors:  Neeraj Narula; Achuthan Aruljothy; Emily C L Wong; Ravi Homenauth; Abdul-Aziz Alshahrani; John K Marshall; Walter Reinisch
Journal:  United European Gastroenterol J       Date:  2021-06-02       Impact factor: 4.623

9.  Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping.

Authors:  Daniel Stekhoven; Almut Scherer; Michael J Nissen; Véronique Grobéty; Nikhil Yawalkar; Peter M Villiger; Burkhard Möller
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

10.  Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4+Foxp3+ Regulatory T Cells.

Authors:  Yuchao Chen; Qunfang Zhang; Huazhen Liu; Chuanjian Lu; Chun-Ling Liang; Feifei Qiu; Ling Han; Zhenhua Dai
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.